Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

TAVIST SYRUP 0.5MG/5ML DIN 01925946

Status: Cancelled Post Market
Holder: SANDOZ CANADA INC
Molecule: CLEMASTINE HYDROGEN FUMARATE

Health Canada record

Active ingredient(s)CLEMASTINE HYDROGEN FUMARATE 0.5 MG
Dosage formSyrup
RouteOral
ScheduleNON-PRESCRIPTION DRUGS
ClassHuman
ATC
Original market date31-Dec-1993
Current status date13-Aug-1996
SourceHealth Canada DPD

Establishment licence of the holder

Sandoz Canada Incorporated — licence 101370, currently licensed, last inspection rating C (2025-02-25).

No Canadian shortage report is currently matched to this DIN.

Request a quote for TAVIST SYRUP 0.5MG/5ML

How to read a Canadian DIN record